Publication: A Wortmannin-Cetuximab as a Double Drug
No Thumbnail Available
Open/View Files
Date
2009
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
American Chemical Society
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Smith, R. Adam, Hushan Yuan, Ralph Weissleder, Lewis C. Cantley, and Lee Josephson. 2009. “A Wortmannin−Cetuximab as a Double Drug.” Bioconjugate Chemistry 20 (11): 2185–89. https://doi.org/10.1021/bc900176a.
Research Data
Abstract
Double drugs are obtained when two pharmacologically active entities are covalently joined to improve potency. We conjugated the viridin Wm with a self-activating linkage to cetuximab and demonstrated the retention of immunoreactivity by the conjugate. Though cetuximab lacked a growth inhibitory activity against A549 cells, the Wm-cetuximab conjugate had an antiproliferative IC(50) of 155 nM in vitro. The chemistry of attaching a self-releasing Wm to clinically approved antibodies is general and, in selected instances, may yield antibody-based double drugs with improved efficacy.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service